Siriraj Hospital
Bangkok, 10700, Thailand
NCT Number: NCT02554617
The purpose of this study is to determine fractional exhaled nitric oxide (FeNO) level in healthy subjects among Thai populations.
Looking for future studies?
Notify Me6 year–60 year
All sexes
Observational
Bangkok, 10700, Thailand
Fractional exhaled nitric oxide (FeNO) were produced from epithelial cells of inflammatory airways and eosinophils and this gas was discovered since 1991.
Fractional exhaled nitric oxide (FeNO) has direct association with severity of inflammation of bronchial trees and sputum eosinophils and use for additional investigation for diagnosis asthma or inflammatory airway diseases.
There are many factors from previous studies that associate with level of fractional exhaled nitric oxide (FeNO), one of that factors is race therefore we can't use level from another studies with different race for use as reference and there is no study about level of fractional exhaled nitric oxide in Thai population.
It is therefore desirable to examine level of fractional exhaled nitric oxide (FeNO) in healthy subjects among Thai population and will be the main objective of this research.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 10 minutes (average time ), on the day of enrollment
Mahidol University
Other
Acronym: FeNO_nor
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02447835
Metabolic Diseases, Normal Non-fluency
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT01366781
Normal Non-fluency
Lund, Sweden
View Trial DetailsNCT01729962
Aphakia, Aphakic Eye
Greensboro, North Carolina, United States
View Trial DetailsNCT01366768
Normal Non-fluency
Lund, Sweden
View Trial Details